Research, News & Discoveries

The Vanderbilt School of Medicine Basic Sciences’ pharmacology department and the Vanderbilt Center for Addiction Research hosted a special event on April 22 focused on the importance of funding for diverse trainees and faculty in academic settings. The speakers discussed the various grants to fund underrepresented trainees and faculty at various stages in their career. Read More

The Lillian B. Nanney Award for Outstanding Service to the VUSM/VUMC Community of Educators is a lifetime achievement award established to recognize an Academy for Excellence in Education faculty member who has demonstrated sustained outstanding service to the Vanderbilt community of educators. This year’s winner is Neil Osheroff, John G. Coniglio Professor of Biochemistry and professor of Medicine. Read More

V2-GENE, the Vanderbilt-Vietnam Genetic Epidemiology Training Program, will develop a team of researchers and educators to lead genetic epidemiology research of noncommunicable diseases across the lifespan in Vietnam. Read More

By targeting a notoriously undruggable protein found in many cancers, the discovery of BI-0474 may pave the way for new cancer treatments. Shared on opnMe.com by Boehringer Ingelheim, this innovative molecule is available for global researchers to explore new research avenues. Read More

Genetic factors are a small but significant contributor to severe depression that does not respond to standard therapy, according to researchers at Vanderbilt University Medical Center and Massachusetts General Hospital. Read More

Foundational research from the Hiebert lab reveals genetic targets that can be leveraged to identify therapies that affect lymphoma cell growth. Read More

By Chuck Sanders, vice dean of the School of Medicine Basic Sciences and professor of biochemistry Joseph Lee Heywood was acquainted with suffering. Having grown up on the New Hampshire/Massachusetts border, as a young man he made his way west to Iowa in search of opportunity. However, before things could… Read More

On average, each graduating student published four scientific papers based on their graduate work. Their research appeared in highly respected journals including Nature, Cell, Human Molecular Genetics and the Proceedings of the National Academy of Sciences, according to Abigail Brown, PhD, director of the Biomedical Research Education and Training Office of Outcomes Research. Read More

New work by Professor of Cell and Developmental Biology Bill Tansey and colleagues has determined that a new type of inhibitor—a WINi—targets cancer cells in a novel way and suggests exploiting this pathway in future anticancer drug development efforts. Read More

One of the monoclonal antibodies in the therapeutic Evusheld has been computationally redesigned to restore its action against Omicron variants of the virus that causes COVID-19. Read More